• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

支付医疗保险优势计划:为了拉平或倾斜竞争环境。

Paying Medicare Advantage plans: To level or tilt the playing field.

机构信息

Tel Aviv University, Israel and University of Warwick, UK.

Department of Health Care Policy, Harvard Medical School and NBER, United States.

出版信息

J Health Econ. 2017 Dec;56:281-291. doi: 10.1016/j.jhealeco.2016.12.004. Epub 2016 Dec 29.

DOI:10.1016/j.jhealeco.2016.12.004
PMID:28318667
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5548660/
Abstract

Medicare beneficiaries are eligible for health insurance through the public option of traditional Medicare (TM) or may join a private Medicare Advantage (MA) plan. Both are highly subsidized but in different ways. Medicare pays for most of costs directly in TM, and subsidizes MA plans based on a "benchmark" for each beneficiary choosing a private plan. The level of this benchmark is arguably the most important policy decision Medicare makes about the MA program. Many analysts recommend equalizing Medicare's subsidy across the options - referred to in policy circles as a "level playing field." This paper studies the normative question of how to set the level of the benchmark, applying the versatile model developed by Einav and Finkelstein (EF) to Medicare. The EF framework implies unequal subsidies to counteract risk selection across plan types. We also study other reasons to tilt the field: the relative efficiency of MA vs. TM, market power of MA plans, and institutional features of the way Medicare determines subsidies and premiums. After review of the empirical and policy literature, we conclude that in areas where the MA market is competitive, the benchmark should be set below average costs in TM, but in areas characterized by imperfect competition in MA, it should be raised in order to offset output (enrollment) restrictions by plans with market power. We also recommend specific modifications of Medicare rules to make demand for MA more price elastic.

摘要

医疗保险受益人有资格通过传统医疗保险(TM)的公共选项或加入私人医疗保险优势(MA)计划获得健康保险。两者都有高额补贴,但方式不同。TM 直接支付大部分费用,而根据选择私人计划的每位受益人的“基准”补贴 MA 计划。基准的水平可以说是医疗保险对 MA 计划做出的最重要的政策决策。许多分析师建议在各种方案中实现医疗保险补贴的均等化——在政策圈中称为“公平竞争环境”。本文应用 Einav 和 Finkelstein(EF)为医疗保险开发的多功能模型,研究了如何设定基准水平的规范性问题。EF 框架意味着需要进行不平等补贴,以抵消不同计划类型之间的风险选择。我们还研究了其他倾斜竞争环境的原因:MA 与 TM 的相对效率、MA 计划的市场力量以及医疗保险确定补贴和保费的方式的制度特征。在审查了实证和政策文献后,我们得出结论,在 MA 市场具有竞争力的领域,基准应设定在 TM 的平均成本以下,但在 MA 中存在不完善竞争的领域,应提高基准以抵消具有市场力量的计划对产出(注册)的限制。我们还建议对医疗保险规则进行具体修改,以提高 MA 的需求价格弹性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c849/5548660/c382b4f6d64a/nihms874771f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c849/5548660/432363039e65/nihms874771f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c849/5548660/ea0841f3f80a/nihms874771f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c849/5548660/f1072299b099/nihms874771f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c849/5548660/100ae454cdde/nihms874771f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c849/5548660/235674c48e37/nihms874771f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c849/5548660/9efcde48e5ea/nihms874771f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c849/5548660/6cdab904695c/nihms874771f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c849/5548660/c382b4f6d64a/nihms874771f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c849/5548660/432363039e65/nihms874771f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c849/5548660/ea0841f3f80a/nihms874771f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c849/5548660/f1072299b099/nihms874771f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c849/5548660/100ae454cdde/nihms874771f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c849/5548660/235674c48e37/nihms874771f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c849/5548660/9efcde48e5ea/nihms874771f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c849/5548660/6cdab904695c/nihms874771f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c849/5548660/c382b4f6d64a/nihms874771f8.jpg

相似文献

1
Paying Medicare Advantage plans: To level or tilt the playing field.支付医疗保险优势计划:为了拉平或倾斜竞争环境。
J Health Econ. 2017 Dec;56:281-291. doi: 10.1016/j.jhealeco.2016.12.004. Epub 2016 Dec 29.
2
Competition Among Medicare's Private Health Plans: Does It Really Exist?医疗保险私人健康计划之间的竞争:它真的存在吗?
Issue Brief (Commonw Fund). 2015 Aug;25:1-14.
3
Medicare Advantage update: benefits, enrollment, and payments after the ACA.医疗保险优势更新:《平价医疗法案》后的福利、参保情况及支付情况
Issue Brief George Wash Univ Natl Health Policy Forum. 2013 Jul 19(850):1-12.
4
The effects of coding intensity in Medicare Advantage on plan benefits and finances.医疗保险优势计划中编码强度对计划福利和财务的影响。
Health Serv Res. 2021 Apr;56(2):178-187. doi: 10.1111/1475-6773.13591. Epub 2020 Nov 9.
5
Physician Reimbursement in Medicare Advantage Compared With Traditional Medicare and Commercial Health Insurance.与传统医疗保险和商业健康保险相比,医疗保险优势计划中的医生报销情况。
JAMA Intern Med. 2017 Sep 1;177(9):1287-1295. doi: 10.1001/jamainternmed.2017.2679.
6
How successful is Medicare Advantage?医疗保险优势计划的成功率如何?
Milbank Q. 2014 Jun;92(2):351-94. doi: 10.1111/1468-0009.12061.
7
Competitive bidding in Medicare Advantage: effect of benchmark changes on plan bids.医疗保险优势计划中的竞争性投标:基准变化对计划投标的影响。
J Health Econ. 2013 Dec;32(6):1301-12. doi: 10.1016/j.jhealeco.2013.09.004.
8
Do Medicare Advantage plans select enrollees in higher margin clinical categories?医疗保险优势计划是否会选择利润率更高的临床类别中的参保人?
J Health Econ. 2013 Dec;32(6):1278-88. doi: 10.1016/j.jhealeco.2013.09.003.
9
Association of Health Insurance Literacy With Enrollment in Traditional Medicare, Medicare Advantage, and Plan Characteristics Within Medicare Advantage.健康保险素养与传统医疗保险、医疗保险优势计划和医疗保险优势计划内计划特征的关联。
JAMA Netw Open. 2022 Feb 1;5(2):e2146792. doi: 10.1001/jamanetworkopen.2021.46792.
10
Making Medicare advantage a middle-class program.使联邦医疗保险优势计划成为中产阶级计划。
J Health Econ. 2013 Mar;32(2):463-73. doi: 10.1016/j.jhealeco.2012.11.010. Epub 2013 Feb 1.

引用本文的文献

1
How to age right and care(fully) at home? A protocol for a multistage comparative study of ageing in place and hospital at home care across three countries.如何在家中正确养老并(细致地)护理?一项关于三个国家原地养老和居家医院护理的多阶段比较研究方案。
BMJ Open. 2025 Apr 2;15(4):e096385. doi: 10.1136/bmjopen-2024-096385.
2
Improving Affordability and Equity in Medicare Advantage.提高医疗保险优势计划的可负担性与公平性。
Inquiry. 2019 Jan-Dec;56:46958019852873. doi: 10.1177/0046958019852873.
3
Measuring efficiency of health plan payment systems in managed competition health insurance markets.

本文引用的文献

1
Upcoding: Evidence from Medicare on Squishy Risk Adjustment.高编计费:来自医疗保险关于模糊风险调整的证据。
J Polit Econ. 2020 Mar;12(3):984-1026. doi: 10.1086/704756. Epub 2020 Jan 29.
2
Paying more for less? Insurer competition and health plan generosity in the Medicare Advantage program.花钱更少,享受更多?医疗保险优势计划中的保险公司竞争与医保计划慷慨性。
J Health Econ. 2018 Sep;61:77-92. doi: 10.1016/j.jhealeco.2018.07.002. Epub 2018 Jul 9.
3
Do Larger Health Insurance Subsidies Benefit Patients or Producers? Evidence from Medicare Advantage.
衡量管理竞争型医疗保险市场中健康计划支付系统的效率。
J Health Econ. 2017 Dec;56:237-255. doi: 10.1016/j.jhealeco.2017.05.004.
更大的医疗保险补贴是有利于患者还是生产者?来自 Medicare Advantage 的证据。
Am Econ Rev. 2018 Aug;108(8):2048-87.
4
How Does Risk Selection Respond to Risk Adjustment? New Evidence from the Medicare Advantage Program.风险选择如何应对风险调整?来自医疗保险优势计划的新证据。
Am Econ Rev. 2014 Oct;104(10):3335-64. doi: 10.1257/aer.104.10.3335.
5
Pricing and Welfare in Health Plan Choice.健康计划选择中的定价与福利
Am Econ Rev. 2012 Dec;102(7):3214-48. doi: 10.1257/aer.102.7.3214.
6
Imperfect risk adjustment, risk preferences, and sorting in competitive health insurance markets.竞争性医疗保险市场中的不完善风险调整、风险偏好和选择。
J Health Econ. 2017 Dec;56:259-280. doi: 10.1016/j.jhealeco.2017.04.004.
7
Traditional Medicare Versus Private Insurance: How Spending, Volume, And Price Change At Age Sixty-Five.传统医疗保险与私人保险:65岁时支出、服务量及价格如何变化
Health Aff (Millwood). 2016 May 1;35(5):864-72. doi: 10.1377/hlthaff.2015.1195.
8
Early Performance of Accountable Care Organizations in Medicare.医疗保险中责任医疗组织的早期表现。
N Engl J Med. 2016 Jun 16;374(24):2357-66. doi: 10.1056/NEJMsa1600142. Epub 2016 Apr 13.
9
HOW MUCH FAVORABLE SELECTION IS LEFT IN MEDICARE ADVANTAGE?医疗保险优势计划中还剩下多少有利选择?
Am J Health Econ. 2015 Winter;1(1):1-26. doi: 10.1162/AJHE_a_00001.
10
A comparison of relative resource use and quality in Medicare Advantage health plans versus traditional Medicare.医疗保险优势健康计划与传统医疗保险在相对资源使用和质量方面的比较。
Am J Manag Care. 2015 Aug;21(8):559-66.